Pharmacovigilance of Radiopharmaceuticals: Challenges and Opportunities.
作者信息
Martins Sara, Jesus Ângelo, Suárez Ana Martín-
机构信息
LAQV/REQUIMTE, Escola Superior de Saúde, Instituto Politécnico do Porto, Porto, Portugal.
Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.
出版信息
J Pharm Technol. 2024 Oct;40(5):257-259. doi: 10.1177/87551225241266172. Epub 2024 Jul 27.
Abstract
摘要
相似文献
1
Pharmacovigilance of Radiopharmaceuticals: Challenges and Opportunities.
J Pharm Technol. 2024 Oct;40(5):257-259. doi: 10.1177/87551225241266172. Epub 2024 Jul 27.
2
Assessment of pharmacovigilance knowledge and ADR reporting skills in undergraduate medical students using the OSPA model.
Dialogues Health. 2025 Jul 3;7:100227. doi: 10.1016/j.dialog.2025.100227. eCollection 2025 Dec.
3
Adverse Reactions to Radiopharmaceuticals: A Survey Based on Clinical Cases Using Criteria of Systematic Review.
Ther Innov Regul Sci. 2018 Jan;52(1):109-113. doi: 10.1177/2168479017716717. Epub 2017 Jun 30.
4
Assessment of knowledge and perceptions of pharmacy students toward pharmacovigilance activities, and their predictors: a cross-sectional study in Palestine.
BMC Med Educ. 2025 Jul 17;25(1):1067. doi: 10.1186/s12909-025-07575-z.
5
Building functional and sustainable pharmacovigilance systems: an analysis of pharmacovigilance development across high-, middle- and low-income countries.
Ther Adv Drug Saf. 2025 Jun 10;16:20420986251342941. doi: 10.1177/20420986251342941. eCollection 2025.
6
Adverse reactions mediated by Tc-tetrofosmin: Literature review and analysis of post-marketing reports.
Rev Esp Med Nucl Imagen Mol (Engl Ed). 2025 Jun 9:500166. doi: 10.1016/j.remnie.2025.500166.
7
Adverse reactions to radiopharmaceuticals in France: analysis of the national pharmacovigilance database.
Ann Pharmacother. 2015 Jan;49(1):39-47. doi: 10.1177/1060028014558153. Epub 2014 Nov 3.
8
Training and education in pharmacovigilance: The experience from the Pharmacovigilance Programme of India.
Indian J Pharmacol. 2024 Sep 1;56(5):348-357. doi: 10.4103/ijp.ijp_638_22. Epub 2024 Dec 16.
9
Pharmacovigilance processes in low- and middle-income countries: moving from data collection to data analysis and interpretation.
Ther Adv Drug Saf. 2025 Jun 11;16:20420986241300006. doi: 10.1177/20420986241300006. eCollection 2025.
10
An observational pilot study of an active surveillance tool to enhance pharmacovigilance in Brazil.
Malar J. 2025 Mar 3;24(1):71. doi: 10.1186/s12936-025-05295-9.
本文引用的文献
1
Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation.
Eur J Med Res. 2024 Jan 5;29(1):26. doi: 10.1186/s40001-023-01627-0.
2
Underreporting of Adverse Drug Events: a Look into the Extent, Causes, and Potential Solutions.
Expert Opin Drug Saf. 2023 Jan-Jun;22(5):351-354. doi: 10.1080/14740338.2023.2224558. Epub 2023 Jun 13.
3
Factors Associated with Underreporting of Adverse Drug Reactions by Health Care Professionals: A Systematic Review Update.
Drug Saf. 2023 Jul;46(7):625-636. doi: 10.1007/s40264-023-01302-7. Epub 2023 Jun 6.
4
Pharmacovigilance: reporting requirements throughout a product's lifecycle.
Ther Adv Drug Saf. 2022 Sep 27;13:20420986221125006. doi: 10.1177/20420986221125006. eCollection 2022.
5
Review of Adverse Reactions Associated with the Use of Common Diagnostic Radiopharmaceuticals.
Indian J Nucl Med. 2021 Apr-Jun;36(2):163-167. doi: 10.4103/ijnm.ijnm_219_20. Epub 2021 Jun 21.
6
Guideline on current good radiopharmacy practice (cGRPP) for the small-scale preparation of radiopharmaceuticals.
EJNMMI Radiopharm Chem. 2021 Feb 12;6(1):8. doi: 10.1186/s41181-021-00123-2.
7
Adverse reactions to radiopharmaceuticals: liver radiopharmaceuticals.
Nucl Med Commun. 2021 Apr 1;42(4):352-359. doi: 10.1097/MNM.0000000000001355.
8
Patient-Reported Adverse Events of Radiopharmaceuticals: A Prospective Study of 1002 Patients.
Drug Saf. 2021 Feb;44(2):211-222. doi: 10.1007/s40264-020-01006-2. Epub 2020 Oct 22.
9
Full report on a survey of adverse reactions to radiopharmaceuticals from 1975 to 2017 in Japan.
Ann Nucl Med. 2020 Apr;34(4):299-304. doi: 10.1007/s12149-020-01439-w. Epub 2020 Jan 27.
10
Adverse Events of Diagnostic Radiopharmaceuticals: A Systematic Review.
Semin Nucl Med. 2019 Sep;49(5):382-410. doi: 10.1053/j.semnuclmed.2019.06.006.
Zotero 插件